Green tea catechin as a chemical chaperone in cancer prevention

Cancer Letters

Volumn 261, Issue 1, 2008, Pages 12-20

  Kuzuhara, Takashi ^a   Suganuma, Masami ^b   Fujiki, Hirota ^a  

^a TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^b SAITAMA CANCER CENTER   (Japan)

Author keywords

Cancer prevention; Chemical chaperone; Conformational analysis; EGCG; Green tea catechin

Indexed keywords

CATECHIN; CHAPERONE; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; GLYCEROL; GREEN TEA EXTRACT; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; RETINOID; SULINDAC; TAMOXIFEN; TREHALOSE;

ARTICLE; BREAST CANCER; CANCER PREVENTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DNA BINDING; DNA DAMAGE; DRUG POTENTIATION; HUMAN; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN INTERACTION; SURFACE PLASMON RESONANCE; TEA;

CATECHIN; MOLECULAR CHAPERONES; NEOPLASMS; PROTEIN CONFORMATION;

EID: 38949218450     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.10.037     Document Type: Article

References (38)

1. Fujiki H., Suganuma M., Imai K., and Nakachi K. Green tea: cancer preventive beverage and/or drug. Cancer Lett. 188 (2002) 9-13
2. Yang C.S., Lambert J.D., Hou Z., Ju J., Lu G., and Hao X. Molecular targets for the cancer preventive activity of tea polyphenols. Mol. Carcinogen. 45 (2006) 431-435
3. NCI, DCPC, Chemoprevention Branch and Agent Development Committee, Clinical development plan: tea extracts green tea polyphenols epigallocatechin gallate, J. Cell. Biochem. 63, 26S (1996) 236-257.
4. Fujiki H. Green tea: health benefits as cancer preventive for humans. Chem Rec. 5 (2005) 119-132
5. S. Yoshizawa, T. Horiuchi, M. Suganuma, S. Nishiwaki, J. Yatsunami, S. Okabe, T. Okuda, Y. Muto, K. Frenkel, W. Troll, Penta-O-galloyl-beta-d-glucose and (-)-epigallocatechin gallate ACS Symp. Series, 507 (1992) 316-325.
6. Chemical Computing Group C, Molecular Operative Enviroment (MOE), 2004, p. 0707.
7. Fujiki H. Two stages of cancer prevention with green tea. J. Cancer Res. Clin. Oncol. 125 (1999) 589-597
8. Tachibana H., Koga K., Fujimura Y., and Yamada K. A receptor for green tea polyphenol EGCG. Nat. Struct. Mol. Biol. 11 (2004) 380-381
9. Ermakova S., Choi B.Y., Choi H.S., Kang B.S., Bode A.M., and Dong Z. The intermediate filament protein vimentin is a new target for epigallocatechin gallate. J. Biol. Chem. 280 (2005) 16882-16890
10. Tamba Y., Ohba S., Kubota M., Yoshioka H., Yoshioka H., and Yamazaki M. Single GUV method reveals interaction of tea catechin (-)-epigallocatechin gallate with lipid membranes. Biophys. J. 92 (2007) 3178-3194
11. Naftalin R.J., Afzal I., Cunningham P., Halai M., Ross C., Salleh N., and Milligan S.R. Interactions of androgens, green tea catechins and the antiandrogen flutamide with the external glucose-binding site of the human erythrocyte glucose transporter GLUT1. Br. J. Pharmacol. 140 (2003) 487-499
12. Nam S., Smith D.M., and Dou Q.P. Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J. Biol. Chem. 276 (2001) 13322-13330
13. Gradisar H., Pristovsek P., Plaper A., and Jerala R. Green tea catechins inhibit bacterial DNA gyrase by interaction with its ATP binding site. J. Med. Chem. 50 (2007) 264-271
14. Leone M., Zhai D., Sareth S., Kitada S., Reed J.C., and Pellecchia M. Cancer prevention by tea polyphenols is linked to their direct inhibition of antiapoptotic Bcl-2-family proteins. Cancer Res. 63 (2003) 8118-8121
15. Sah J.F., Balasubramanian S., Eckert R.L., and Rorke E.A. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases. J. Biol. Chem. 279 (2004) 12755-12762
16. Wang X., and Tian W. Green tea epigallocatechin gallate: a natural inhibitor of fatty-acid synthase. Biochem. Biophys. Res. Commun. 288 (2001) 1200-1206
17. Abe I., Kashiwagi K., and Noguchi H. Antioxidative galloyl esters as enzyme inhibitors of p-hydroxybenzoate hydroxylase. FEBS Lett. 483 (2000) 131-134
18. Abe I., Seki T., Umehara K., Miyase T., Noguchi H., Sakakibara J., and Ono T. Green tea polyphenols: novel and potent inhibitors of squalene epoxidase. Biochem. Biophys. Res. Commun. 268 (2000) 767-771
19. Bertoldi M., Gonsalvi M., and Voltattorni C.B. Green tea polyphenols: novel irreversible inhibitors of dopa decarboxylase. Biochem. Biophys. Res. Commun. 284 (2001) 90-93
20. Liao S., and Hiipakka R.A. Selective inhibition of steroid 5 alpha-reductase isozymes by tea epicatechin-3-gallate and epigallocatechin-3-gallate. Biochem. Biophys. Res. Commun. 214 (1995) 833-838
21. 2 at physiologically relevant EGCG concentrations. Biochem. Biophys. Res. Commun. 296 (2002) 584-588
22. Shimizu M., Deguchi A., Hara Y., Moriwaki H., and Weinstein I.B. EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells. Biochem. Biophys. Res. Commun. 334 (2005) 947-953
23. Jodoin J., Demeule M., and Beliveau R. Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols. Biochim. Biophys. Acta 1542 (2002) 149-159
24. Tosetti F., Ferrari N., De Flora S., and Albini A. Angioprevention: angiogenesis is a common and key target for cancer chemopreventive agents. FASEB J. 16 (2002) 2-14
25. Kuzuhara T., Sei Y., Yamaguchi K., Suganuma M., and Fujiki H. DNA and RNA as new binding targets of green tea catechins. J. Biol. Chem. 281 (2006) 17446-17456
26. Kuzuhara T., Tanabe A., Sei Y., Yamaguchi K., Suganuma M., and Fujiki H. Synergistic effects of multiple treatments, and both DNA and RNA direct bindings on, green tea catechins. Mol. Carcinogen. 46 (2007) 640-645
27. Davies J.E., Sarkar S., and Rubinsztein D.C. Trehalose reduces aggregate formation and delays pathology in a transgenic mouse model of oculopharyngeal muscular dystrophy. Hum. Mol. Genet. 15 (2006) 23-31
28. Ohnishi K., Ota I., Takahashi A., and Ohnishi T. Glycerol restores p53-dependent radiosensitivity of human head and neck cancer cells bearing mutant p53. Br. J. Cancer 83 (2000) 1735-1739
29. Ozcan U., Yilmaz E., Ozcan L., Furuhashi M., Vaillancourt E., Smith R.O., Görgün C.Z., and Hotamisligil G.S. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313 (2006) 1137-1140
30. Wiseman R.L., and Balch W.E. A new pharmacology-drugging stressed folding pathways. Trends Mol. Med. 11 (2005) 347-350
31. Skrzypczak-Jankun E., Zhou K., and Jankun J. Inhibition of lipoxygenase by (-)-epigallocatechin gallate: X-ray analysis at 2.1 Å reveals degradation of EGCG and shows soybean LOX-3 complex with EGC instead. Int. J. Mol. Med. 12 (2003) 415-420
32. Suganuma M., Okabe S., Kai Y., Sueoka N., Sueoka E., and Fujiki H. Synergistic effects of (-)-epigallocatechin gallate with (-)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9. Cancer Res. 59 (1999) 44-47
33. Nakamura G., Narimatsu K., Niidome Y., and Nakashima N. Green tea solution individually solubilize single-walled carbon nanotubes. Chem. Lett. 36 (2007) 1140-1141
34. Okabe S., Suganuma M., Hayashi M., Sueoka E., Komori A., and Fujiki H. Mechanisms of growth inhibition of human lung cancer cell line, PC-9, by tea polyphenols. Jpn. J. Cancer Res. 88 (1997) 639-643
35. Suganuma M., Ohkura Y., Okabe S., and Fujiki H. Combination of cancer chemoprevention with green tea extract and sulindac shown in intestinal tumor formation in Min mice. J. Cancer Res. Clin. Oncol. 127 (2001) 69-72
36. Nakachi K., Matsuyama S., Miyake S., Suganuma M., and Imai K. Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. BioFactors 13 (2000) 49-54
37. Nakachi K., Suemasu K., Suga K., Takeo T., Imai K., and Higashi Y. Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn. J. Cancer Res. 89 (1998) 254-261
38. Bettuzzi S., Brausi M., Rizzi F., Castagnetti G., Peracchia G., and Corti A. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res. 66 (2006) 1234-1240